• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.

作者信息

Leier C V, Desch C E, Magorien R D, Triffon D W, Unverferth D V, Boudoulas H, Lewis R P

出版信息

Am J Cardiol. 1980 Dec 1;46(6):1039-44. doi: 10.1016/0002-9149(80)90364-1.

DOI:10.1016/0002-9149(80)90364-1
PMID:7446418
Abstract

Hydralazine possesses positive inotropic properties in animal model preparations. To determine whether this vasodilator elicits a positive inotropic response in the failing human ventricle, hydralazine, 75 or 100 mg, was administered orally to 14 patients with left ventricular dysfunction and congestive heart failure; the results were compared with those of first-dose prazosin at 5 and 10 mg. The duration of the preejection period and the isovolumic developed pressure/duration of isovolumic contraction (delta P/delta t) were used as indexes of inotropy. Prazosin did not effect a significant response in the duration of the preejection period or in the delta P/delta t. Hydralazine significantly shortened the preejection period and increased the delta P/delta t over 8 hours after administration; these data suggest that hydralazine elicits a positive inotropic response in the failing human ventricle.

摘要

相似文献

1
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
Am J Cardiol. 1980 Dec 1;46(6):1039-44. doi: 10.1016/0002-9149(80)90364-1.
2
Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Clin Pharmacol Ther. 1981 Jul;30(1):23-30. doi: 10.1038/clpt.1981.122.
3
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Circulation. 1982 Apr;65(4):671-8. doi: 10.1161/01.cir.65.4.671.
4
Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Circulation. 1980 Jun;61(6):1212-6. doi: 10.1161/01.cir.61.6.1212.
5
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Ann Intern Med. 1981 Jul;95(1):5-13. doi: 10.7326/0003-4819-95-1-5.
6
Clonidine in congestive heart failure: a vasodilator with negative inotropic effects.
Am J Cardiol. 1983 Mar 1;51(5):791-5. doi: 10.1016/s0002-9149(83)80135-0.
7
Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
Cardiology. 1980;66(4):193-8. doi: 10.1159/000170866.
8
Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Acta Med Scand Suppl. 1981;652:163-8. doi: 10.1111/j.0954-6820.1981.tb06809.x.
9
Vasodilator therapy of chronic congestive heart failure.
J Med Assoc Ga. 1980 Feb;69(2):131-2.
10
Effect of prazosin vs placebo on chronic left ventricular heart failure.
Circulation. 1979 Feb;59(2):344-50. doi: 10.1161/01.cir.59.2.344.

引用本文的文献

1
Cellular mechanism of the positive inotropic effect of hydralazine in mammalian myocardium.肼屈嗪对哺乳动物心肌正性肌力作用的细胞机制。
Br J Pharmacol. 1993 Jul;109(3):667-72. doi: 10.1111/j.1476-5381.1993.tb13625.x.
2
Usefulness of the systolic time intervals in cardiovascular clinical cardiology.收缩期时间间期在心血管临床心脏病学中的应用价值。
Trans Am Clin Climatol Assoc. 1982;93:108-20.
3
Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacology.
收缩期时间间期:健康、疾病及临床药理学中的心功能无创性检查方法综述
Postgrad Med J. 1983 Jul;59(693):423-34. doi: 10.1136/pgmj.59.693.423.
4
Vasodilator therapy in chronic congestive heart failure.慢性充血性心力衰竭的血管扩张剂治疗
Drugs. 1983 Aug;26(2):148-73. doi: 10.2165/00003495-198326020-00003.
5
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.哌唑嗪最新进展。对其药理特性以及在高血压和充血性心力衰竭治疗中的应用综述。
Drugs. 1983 Apr;25(4):339-84. doi: 10.2165/00003495-198325040-00002.
6
Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.卡托普利及肼屈嗪与硝酸异山梨酯联合用药对重度充血性心力衰竭患者心肌交感神经张力的影响
Br Heart J. 1986 Aug;56(2):152-7. doi: 10.1136/hrt.56.2.152.
7
Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
Cardiovasc Drugs Ther. 1988 Jan;1(5):529-34. doi: 10.1007/BF02125736.
8
Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.肼屈嗪在充血性心力衰竭中的临床药代动力学及治疗应用
Clin Pharmacokinet. 1989 Feb;16(2):86-9. doi: 10.2165/00003088-198916020-00003.